These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31880035)

  • 1. Psychological distress at hospital admission is related to symptoms severity and health status in malignant pleural effusion patients.
    Rodríguez Torres J; Cabrera Martos I; López López L; Torres Sánchez I; Granados Santiago M; Valenza MC
    Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13212. PubMed ID: 31880035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia in patients with malignant pleural effusion: impact on symptoms, health status, and response to hospitalization.
    Rodríguez-Torres J; López-López L; Cabrera-Martos I; Valenza-Demet G; Cahalin LP; Valenza MC
    Support Care Cancer; 2019 Dec; 27(12):4655-4663. PubMed ID: 30944992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Costs and Utilization among Patients Hospitalized for Malignant Pleural Effusion.
    Shafiq M; Ma X; Taghizadeh N; Kharrazi H; Feller-Kopman DJ; Tremblay A; Yarmus LB
    Respiration; 2020; 99(3):257-263. PubMed ID: 32155630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
    Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
    BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological distress prior to surgery is related to symptom burden and health status in lung cancer survivors.
    Linares-Moya M; Rodríguez-Torres J; Heredia-Ciuró A; Granados-Santiago M; López-López L; Quero-Valenzuela F; Valenza MC
    Support Care Cancer; 2022 Feb; 30(2):1579-1586. PubMed ID: 34541609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
    Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
    BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
    Porcel JM; Solé C; Salud A; Bielsa S
    Lung; 2017 Dec; 195(6):775-779. PubMed ID: 28900718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Low-Cost, Long-Term Indwelling Pleural Catheter (LunGO): An Inexpensive and Effective Alternative for the Management of Dyspnea Associated with Malignant Pleural Effusions.
    de Abreu IRLB; Bina Biazzotto AF; Santos MA; de Souza AAC; Abrão FC; Cavalcante MGC
    Respiration; 2019; 98(2):151-156. PubMed ID: 31018214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIFFERENCES IN CLINICAL MANIFESTATIONS AND PLEURAL FLUID CHARATERISTICS BETWEEN TUBERCULOUS AND MALIGNANT PLEURAL EFFUSIONS.
    Saiphoklang N; Kanitsap A; Nambunchu A
    Southeast Asian J Trop Med Public Health; 2015 May; 46(3):496-503. PubMed ID: 26521524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
    Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
    J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
    Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
    Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?
    Abrao FC; Peixoto RD; de Abreu IR; Janini MC; Viana GG; de Oliveira MC; Younes RN
    J Surg Oncol; 2016 Apr; 113(5):570-4. PubMed ID: 26751412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
    Abisheganaden J; Verma A; Dagaonkar RS; Light RW
    Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion.
    Boshuizen RC; Vincent AD; van den Heuvel MM
    Support Care Cancer; 2013 Nov; 21(11):3109-16. PubMed ID: 23842597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Pleural Effusion and Its Current Management: A Review.
    Skok K; Hladnik G; Grm A; Crnjac A
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
    Mishra EK; Corcoran JP; Hallifax RJ; Stradling J; Maskell NA; Rahman NM
    PLoS One; 2015; 10(4):e0123798. PubMed ID: 25874452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.